Global Companion Diagnostic Market Research Report 2023

Report ID: 1982554 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Immunohistochemistry
        1.2.3 Molecular Diagnosis
    1.3 Market by Application
        1.3.1 Global Companion Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Virology
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Companion Diagnostic Market Perspective (2017-2028)
    2.2 Companion Diagnostic Growth Trends by Region
        2.2.1 Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Companion Diagnostic Historic Market Size by Region (2017-2022)
        2.2.3 Companion Diagnostic Forecasted Market Size by Region (2023-2028)
    2.3 Companion Diagnostic Market Dynamics
        2.3.1 Companion Diagnostic Industry Trends
        2.3.2 Companion Diagnostic Market Drivers
        2.3.3 Companion Diagnostic Market Challenges
        2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Companion Diagnostic Players by Revenue
        3.1.1 Global Top Companion Diagnostic Players by Revenue (2017-2022)
        3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2017-2022)
    3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Companion Diagnostic Revenue
    3.4 Global Companion Diagnostic Market Concentration Ratio
        3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021
    3.5 Companion Diagnostic Key Players Head office and Area Served
    3.6 Key Players Companion Diagnostic Product Solution and Service
    3.7 Date of Enter into Companion Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
    4.1 Global Companion Diagnostic Historic Market Size by Type (2017-2022)
    4.2 Global Companion Diagnostic Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostic Breakdown Data by Application
    5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022)
    5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Companion Diagnostic Market Size (2017-2028)
    6.2 North America Companion Diagnostic Market Size by Country (2017-2022)
    6.3 North America Companion Diagnostic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Companion Diagnostic Market Size (2017-2028)
    7.2 Europe Companion Diagnostic Market Size by Country (2017-2022)
    7.3 Europe Companion Diagnostic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Companion Diagnostic Market Size (2017-2028)
    8.2 Asia-Pacific Companion Diagnostic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Companion Diagnostic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Companion Diagnostic Market Size (2017-2028)
    9.2 Latin America Companion Diagnostic Market Size by Country (2017-2022)
    9.3 Latin America Companion Diagnostic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Companion Diagnostic Market Size (2017-2028)
    10.2 Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche Holdings
        11.1.1 Roche Holdings Company Detail
        11.1.2 Roche Holdings Business Overview
        11.1.3 Roche Holdings Companion Diagnostic Introduction
        11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2017-2022)
        11.1.5 Roche Holdings Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Detail
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories Companion Diagnostic Introduction
        11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022)
        11.2.5 Abbott Laboratories Recent Development
    11.3 Thermo Fisher Scientific
        11.3.1 Thermo Fisher Scientific Company Detail
        11.3.2 Thermo Fisher Scientific Business Overview
        11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
        11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022)
        11.3.5 Thermo Fisher Scientific Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Detail
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies Companion Diagnostic Introduction
        11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022)
        11.4.5 Agilent Technologies Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Companion Diagnostic Introduction
        11.5.4 Merck Revenue in Companion Diagnostic Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Agendia
        11.6.1 Agendia Company Detail
        11.6.2 Agendia Business Overview
        11.6.3 Agendia Companion Diagnostic Introduction
        11.6.4 Agendia Revenue in Companion Diagnostic Business (2017-2022)
        11.6.5 Agendia Recent Development
    11.7 Qiagen
        11.7.1 Qiagen Company Detail
        11.7.2 Qiagen Business Overview
        11.7.3 Qiagen Companion Diagnostic Introduction
        11.7.4 Qiagen Revenue in Companion Diagnostic Business (2017-2022)
        11.7.5 Qiagen Recent Development
    11.8 Myriad Genetics
        11.8.1 Myriad Genetics Company Detail
        11.8.2 Myriad Genetics Business Overview
        11.8.3 Myriad Genetics Companion Diagnostic Introduction
        11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022)
        11.8.5 Myriad Genetics Recent Development
    11.9 Advanced Cell Diagnostics
        11.9.1 Advanced Cell Diagnostics Company Detail
        11.9.2 Advanced Cell Diagnostics Business Overview
        11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
        11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022)
        11.9.5 Advanced Cell Diagnostics Recent Development
    11.10 Danaher
        11.10.1 Danaher Company Detail
        11.10.2 Danaher Business Overview
        11.10.3 Danaher Companion Diagnostic Introduction
        11.10.4 Danaher Revenue in Companion Diagnostic Business (2017-2022)
        11.10.5 Danaher Recent Development
    11.11 Illumina, Inc
        11.11.1 Illumina, Inc Company Detail
        11.11.2 Illumina, Inc Business Overview
        11.11.3 Illumina, Inc Companion Diagnostic Introduction
        11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022)
        11.11.5 Illumina, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Immunohistochemistry
    Table 3. Key Players of Molecular Diagnosis
    Table 4. Global Companion Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Companion Diagnostic Market Share by Region (2017-2022)
    Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Companion Diagnostic Market Share by Region (2023-2028)
    Table 10. Companion Diagnostic Market Trends
    Table 11. Companion Diagnostic Market Drivers
    Table 12. Companion Diagnostic Market Challenges
    Table 13. Companion Diagnostic Market Restraints
    Table 14. Global Companion Diagnostic Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Companion Diagnostic Market Share by Players (2017-2022)
    Table 16. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
    Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Companion Diagnostic Product Solution and Service
    Table 21. Date of Enter into Companion Diagnostic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Companion Diagnostic Revenue Market Share by Type (2017-2022)
    Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Companion Diagnostic Revenue Market Share by Type (2023-2028)
    Table 27. Global Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Companion Diagnostic Revenue Market Share by Application (2017-2022)
    Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Companion Diagnostic Revenue Market Share by Application (2023-2028)
    Table 31. North America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Companion Diagnostic Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Roche Holdings Company Detail
    Table 42. Roche Holdings Business Overview
    Table 43. Roche Holdings Companion Diagnostic Product
    Table 44. Roche Holdings Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 45. Roche Holdings Recent Development
    Table 46. Abbott Laboratories Company Detail
    Table 47. Abbott Laboratories Business Overview
    Table 48. Abbott Laboratories Companion Diagnostic Product
    Table 49. Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 50. Abbott Laboratories Recent Development
    Table 51. Thermo Fisher Scientific Company Detail
    Table 52. Thermo Fisher Scientific Business Overview
    Table 53. Thermo Fisher Scientific Companion Diagnostic Product
    Table 54. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 55. Thermo Fisher Scientific Recent Development
    Table 56. Agilent Technologies Company Detail
    Table 57. Agilent Technologies Business Overview
    Table 58. Agilent Technologies Companion Diagnostic Product
    Table 59. Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 60. Agilent Technologies Recent Development
    Table 61. Merck Company Detail
    Table 62. Merck Business Overview
    Table 63. Merck Companion Diagnostic Product
    Table 64. Merck Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 65. Merck Recent Development
    Table 66. Agendia Company Detail
    Table 67. Agendia Business Overview
    Table 68. Agendia Companion Diagnostic Product
    Table 69. Agendia Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 70. Agendia Recent Development
    Table 71. Qiagen Company Detail
    Table 72. Qiagen Business Overview
    Table 73. Qiagen Companion Diagnostic Product
    Table 74. Qiagen Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 75. Qiagen Recent Development
    Table 76. Myriad Genetics Company Detail
    Table 77. Myriad Genetics Business Overview
    Table 78. Myriad Genetics Companion Diagnostic Product
    Table 79. Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 80. Myriad Genetics Recent Development
    Table 81. Advanced Cell Diagnostics Company Detail
    Table 82. Advanced Cell Diagnostics Business Overview
    Table 83. Advanced Cell Diagnostics Companion Diagnostic Product
    Table 84. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 85. Advanced Cell Diagnostics Recent Development
    Table 86. Danaher Company Detail
    Table 87. Danaher Business Overview
    Table 88. Danaher Companion Diagnostic Product
    Table 89. Danaher Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 90. Danaher Recent Development
    Table 91. Illumina, Inc Company Detail
    Table 92. Illumina, Inc Business Overview
    Table 93. Illumina, Inc Companion DiagnosticProduct
    Table 94. Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 95. Illumina, Inc Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Companion Diagnostic Market Share by Type: 2021 VS 2028
    Figure 2. Immunohistochemistry Features
    Figure 3. Molecular Diagnosis Features
    Figure 4. Global Companion Diagnostic Market Share by Application in 2021 & 2028
    Figure 5. Oncology Case Studies
    Figure 6. Cardiovascular Case Studies
    Figure 7. Central Nervous System Case Studies
    Figure 8. Virology Case Studies
    Figure 9. Others Case Studies
    Figure 10. Companion Diagnostic Report Years Considered
    Figure 11. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Companion Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Companion Diagnostic Market Share by Region: 2021 VS 2028
    Figure 14. Global Companion Diagnostic Market Share by Players in 2021
    Figure 15. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2021
    Figure 17. North America Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Companion Diagnostic Market Share by Country (2017-2028)
    Figure 19. United States Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Companion Diagnostic Market Share by Country (2017-2028)
    Figure 23. Germany Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Companion Diagnostic Market Share by Region (2017-2028)
    Figure 31. China Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Companion Diagnostic Market Share by Country (2017-2028)
    Figure 39. Mexico Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Companion Diagnostic Market Share by Country (2017-2028)
    Figure 43. Turkey Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 46. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 48. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 50. Agendia Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 51. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 52. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 53. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 54. Danaher Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 55. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc
Frequently Asked Questions
Companion Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Companion Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Companion Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Composite Preforms

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More